Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Sep 12;9:CD006794. doi: 10.1002/14651858.CD006794.pub3
Methods RCT.
Participants 100 primigravidas at term were randomly assigned to 2 groups:active management (n = 50) and control group (n = 50)
Interventions Women in the intervention group were managed by early amniotomy and augmentation with oxytocin at 6 miu/mL. In the control group, women received conservative care, amniotomy after 6 cm dilatation and oxytocin at 1 miu/mL
Outcomes CS; length of labour; maternal and neonatal morbidity and mortality
Notes Prevention trial. Nulliparous women.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Only abstract information available.
Allocation concealment (selection bias) Unclear risk Only abstract information available.
Blinding of participants and personnel (performance bias)
All outcomes
High risk The participants were not blinded to the treatment.
Blinding of outcome assessment (detection bias)
All outcomes
High risk The clinicians were not blinded to the treatment.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only abstract information available.
Selective reporting (reporting bias) Unclear risk Only abstract information available.
Other bias Unclear risk Only abstract information available.